A patient with primary biliary cirrhosis and elevated LDL cholesterol

Clinical Chemistry

Volumn 55, Issue 1, 2009, Pages 187-191

  Foley, Kevin F ^a   Silveira, Marina G ^b   Hornseth, Jean M ^b   Lindor, Keith D ^b   McConnell, Joseph P ^b  

^a NORTHERN MICHIGAN UNIVERSITY   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN X; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MITOCHONDRION ANTIBODY; URSODEOXYCHOLIC ACID;

ADULT; ANAMNESIS; ARTICLE; ATHEROSCLEROSIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIVER BIOPSY; PATIENT COUNSELING; PHYSICAL EXAMINATION; PRIMARY BILIARY CIRRHOSIS; SMOKING CESSATION;

CHOLESTEROL, LDL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS, BILIARY; MIDDLE AGED; URSODEOXYCHOLIC ACID;

EID: 58149213972     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.108720     Document Type: Article

References (10)

1. Seidel D, Alaupovic P, Furman RH. A lipoprotein characterizing obstructive jaundice, I: method for quantitative separation and identification of lipoproteins in jaundiced subjects. J Clin Invest 1969;48:1211-23.
2. Seidel D, Alaupovic P, Furman RH, McConathy WJ. A lipoprotein characterizing obstructive jaundice, II: isolation and partial characterization of the protein moieties of low density lipoproteins. J Clin Invest 1970;49:2396-407.
3. Narayanan S. Biochemistry and clinical relevance of lipoprotein X. Ann Clin Lab Sci 1984;14:371-4.
4. Zhu X, Herzenberg AM, Eskandarian M, Maguire GF, Scholey JW, Connelly PW, Ng DS. A novel in vivo lecithin-cholesterol acyltransferase (LCAT)-deficient mouse expressing predominantly LpX is associated with spontaneous glomerulopathy. Am J Pathol 2004;165:1269-78.
5. Sorokin A, Brown JL, Thompson PD. Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: a systematic review. Atherosclerosis 2007;194:293-9.
6. Chang PY, Lu SC, Su TC, Chou SF, Huang WH, Morrisett JD, et al. Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation. J Lipid Res 2004;45:2116-22.
7. Fei H, Maeda S, Kirii H, Fujigaki S, Maekawa N, Fujii H, et al. Evaluation of two different homogeneous assays for LDL-cholesterol in lipoprotein-X-positive serum. Clin Chem 2000;46:1351-6.
8. Herzum I, Giehl C, Soufi M, Junclas H, Wahl HG. Interference in a homogeneous assay for low-density lipoprotein cholesterol by lipoprotein X. Clin Chem Lab Med 2007;45:667-71.
9. Coakley JC, Vervaart PP, McKay MR. Factitious hyponatremia in a patient with cholestatic jaundice following bone marrow transplantation. Pathology 1986;18:158-9.
10. Beaudeux JL, Peynet J, Flourie F, Keddad K, Delattre J, Rousselet F, Legrand A. Discrepancies between lipoprotein(a) concentrations in icteric sera measured by immunonephelometry and electroimmunodiffusion. Clin Biochem 1994;27:7-11.